For Immediate Release:
|Allen & Caron Inc||CLOSURE Medical Corp|
|Joe Allen (investors)||Len Hall (media)||Daniel Pelak, CEO|
|(212) 691-8087||(949) 474-4300||Benny Ward, CFO|
BAND-AID® BRAND LIQUID BANDAGE RECEIVES
GOOD HOUSEKEEPING’S “GOOD BUY” AWARD
RALEIGH, NC (January 22, 2003) … CLOSURE Medical Corporation (Nasdaq:CLSR), a medical tissue adhesive products company, announced that BAND-AID® Brand liquid bandage, which it developed for Johnson & Johnson Consumer Products Company, was one of only seven products to receive a Good Housekeeping “Good Buy” Award for best new household products introduced during 2002. It was the only personal healthcare product to win the award this year.
BAND-AID® Brand Liquid Bandage is an adhesive which is applied to minor cuts and scrapes forming a flexible covering, sealing them from dirt and germs. It allows natural healing to take place quickly and sloughs off naturally as the wound heals. Johnson & Johnson Consumer Products Company began marketing BAND-AID® Brand Liquid Bandage in February 2002.
The Good Housekeeping Institute tests a multitude of products during the year in search of those exhibiting value, performance and ingenuity. BAND-AID® Brand Liquid Bandage was found to be an “innovative solution to save consumers time, money and aggravation” according to Good Housekeeping. The Eighth Annual “Good Buy” Award winners appear in the January 2003 issue of Good Housekeeping.
“The Good Housekeeping ‘Good Buy’ award is a tribute to the liquid bandage technology as it recognizes CLOSURE’s ability to create innovative new products that fulfill consumer needs. Along with our marketing partner, J&J, we look forward to introducing additional, innovative products based on our core technology,” said Daniel Pelak, President and CEO.
About CLOSURE Medical Corp
CLOSURE Medical Corporation is a global leader in the development, manufacture, and commercialization of medical adhesive brands for wound closure and care based on its proprietary medical grade cyanoacrylate technology. CLOSURE’s proprietary technology has customized the physical and chemical properties of cyanoacrylates to develop medical adhesive formulations to close and seal topical skin wounds and incisions.
For additional information on CLOSURE Medical visit its website at www.closuremed.com or visit the “Clients” section of the Allen & Caron website at www.allencaron.com.
This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties or other factors not under the Company’s control which may cause actual results, performance or achievements of the Company to be materially different from the results, performance, or other expectations implied by these forward-looking statements. These factors include, but are not limited to the early stage of commercialization of the Company’s products; the progress of its research and development programs for future products; the need for regulatory approval and effects of governmental regulation; technological uncertainties; the satisfactory conclusion of negotiations with, and dependence on marketing partners, and dependence on patents and trade secrets, as well as those detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2001, filed with the Securities and Exchange Commission. Although the Company believes that the expectations in the forward-looking statements are reasonable, the Company cannot guarantee such results. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.